Aleksandar Sekulic

Nonlinear mixed effects dose response modeling in high throughput drug screens: application to melanoma cell line analysis

Jeffrey M. Trent, Darren Finlay, Kristiina Vuori, 2018, Oncotarget.

Characterization of Task-based Benchmarks from the Barcelona OpenMP Task Suite

Aleksandar Sekulic, Johan Elander Aman, 2013 .

Concept of spatial coordinate systems, their defining and implementation as a precondition in geospatial applications

Aleksandar Sekulic, Zoran Nedeljkovic, 2015 .

Somatic selection distinguishes oncogenes and tumor suppressor genes

Junwen Wang, Carlo C. Maley, Aleksandar Sekulic, 2019, Bioinform..

Pilot Trial of Selecting Molecularly Guided Therapy for Patients with Non–V600 BRAF-Mutant Metastatic Melanoma: Experience of the SU2C/MRA Melanoma Dream Team

Aleksandar Sekulic, Jeffrey M Trent, Sally Hunsberger, 2015, Molecular Cancer Therapeutics.

Advanced basal cell carcinoma of the skin: targeting the hedgehog pathway

Aleksandar Sekulic, P. LoRusso, D. Northfelt, 2013, Current opinion in oncology.

Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.

Aleksandar Sekulic, Daniel Berg, Wade L Thorstad, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

Analysis of variability in high throughput screening data: applications to melanoma cell lines and drug responses

Darren Finlay, Kristiina Vuori, Kuan-Fu Ding, 2017, Oncotarget.

Loss of Inositol Polyphosphate 5-Phosphatase Is an Early Event in Development of Cutaneous Squamous Cell Carcinoma

Aleksandar Sekulic, Michael Bittner, Clara Curiel-Lewandrowski, 2010, Cancer Prevention Research.

Efficacy and safety of vismodegib in advanced basal-cell carcinoma.

Aleksandar Sekulic, Michael R Migden, Axel Hauschild, 2012, The New England journal of medicine.